Entera Bio annual total assets
2017
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Total Assets Growth & History (ENTX)
Entera Bio's total assets was $16.0M for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.0M | $6.6M | +70.32% |
| 2024 | 2024-12-31 | $9.4M | −$2.4M | −20.19% |
| 2023 | 2023-12-31 | $11.8M | −$1.4M | −10.38% |
| 2022 | 2022-12-31 | $13.1M | −$12.9M | −49.49% |
| 2021 | 2021-12-31 | $26.0M | $16.3M | +167.30% |
| 2020 | 2020-12-31 | $9.7M | −$7.0M | −41.79% |
| 2019 | 2019-12-31 | $16.7M | $3.4M | +25.20% |
| 2018 | 2018-12-31 | $13.3M | $63,000 | +0.47% |
| 2017 | 2017-12-31 | $13.3M | — | — |
Entera Bio quarterly total assets
Q4.17
Q4.18
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $19.5M | −$187,000 | −0.95% |
| Q1 2026 | 2026-03-31 | $13.1M | −$8.5M | −39.22% |
| Q4 2025 | 2025-12-31 | $16.0M | $6.6M | +70.32% |
| Q3 2025 | 2025-09-30 | $17.4M | $9.7M | +124.87% |
| Q2 2025 | 2025-06-30 | $19.7M | $9.6M | +95.98% |
| Q1 2025 | 2025-03-31 | $21.6M | $11.4M | +110.96% |
| Q4 2024 | 2024-12-31 | $9.4M | −$2.4M | −20.19% |
| Q3 2024 | 2024-09-30 | $7.7M | −$824,000 | −9.62% |
| Q2 2024 | 2024-06-30 | $10.0M | −$410,000 | −3.93% |
| Q1 2024 | 2024-03-31 | $10.2M | −$1.4M | −11.78% |
| Q4 2023 | 2023-12-31 | $11.8M | −$1.4M | −10.38% |
| Q3 2023 | 2023-09-30 | $8.6M | −$7.0M | −44.88% |
| Q2 2023 | 2023-06-30 | $10.4M | −$8.6M | −45.28% |
| Q1 2023 | 2023-03-31 | $11.6M | −$10.7M | −47.98% |
| Q4 2022 | 2022-12-31 | $13.1M | −$12.9M | −49.49% |
| Q3 2022 | 2022-09-30 | $15.5M | — | — |
| Q2 2022 | 2022-06-30 | $19.1M | −$9.9M | −34.04% |
| Q1 2022 | 2022-03-31 | $22.3M | — | — |
| Q4 2021 | 2021-12-31 | $26.0M | $16.3M | +167.30% |
| Q2 2021 | 2021-06-30 | $28.9M | $17.5M | +152.48% |
| Q4 2020 | 2020-12-31 | $9.7M | −$7.0M | −41.79% |
| Q2 2020 | 2020-06-30 | $11.5M | — | — |
| Q4 2019 | 2019-12-31 | $16.7M | $3.4M | +25.20% |
| Q4 2018 | 2018-12-31 | $13.3M | $63,000 | +0.47% |
| Q4 2017 | 2017-12-31 | $13.3M | — | — |
Entera Bio total assets trends
Over the last five fiscal years, Entera Bio's total assets increased from $9.7M to $16.0M, a change of $6.3M. The latest reported quarter, Q2 2026, shows $19.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗